Home / Industry / Weight-Loss Drugmakers Lobby for Medicare Coverage

Back

Weight-Loss Drugmakers Lobby for Medicare Coverage

wsj

4 min read The Wall Street Journal 24 Apr 2023, 06:23 PM IST

Adding Ozempic, Mounjaro to federal plans could stoke sales

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes and made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. May 29, 2023. REUTERS/George Frey (REUTERS) — A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes and made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. May 29, 2023. REUTERS/George Frey (REUTERS)

Weight-loss drugmakers are lobbying Congress to grant them access to a monster payday for their blockbuster treatments: Medicare coverage.

×

Get alerts on WhatsApp

Set Preferences My Reads Watchlist Feedback Redeem a Gift Card Logout